Epidemiology-based wastewater monitoring for ecological risks of anti-tuberculosis drugs mixture effects

被引:2
|
作者
Chen, Wei -Yu [1 ]
Chen, Yi-Fang [2 ]
Tsai, Jer-Min [3 ]
Huang, Hsin-Mei [1 ]
Su, Yong -Chao [2 ]
机构
[1] Natl Univ Tainan, Dept Ecol & Environm Resources, Tainan, Taiwan
[2] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan
[3] Kun Shan Univ, Dept Informat & Commun, Tainan, Taiwan
关键词
Anti -tuberculosis drugs; Mixture toxicity; Daphnia magna; Epidemic models; Ecotoxicological risk; PULMONARY TUBERCULOSIS; SEASONALITY; TOXICITY; RIFAMPICIN; ETHAMBUTOL; ANTIBIOTICS; INFLUENZA; HEPATOTOXICITY; NEUROTOXICITY; HEPATOCYTES;
D O I
10.1016/j.scitotenv.2023.164560
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
First-line anti-tuberculosis (TB) drugs are commonly used to treat TB worldwide, leading to more contaminated wastewater being widely discharged into aquatic environments. However, studies of mixture interactions of anti-TB drugs and their residues in aquatic environments are scarce. This study aimed to determine the toxic interactions of antiTB drugs-isoniazid (INH), rifampicin (RMP), and ethambutol (EMB)-in binary and ternary mixtures on Daphnia magna and used the epidemiology of TB history to construct epidemiology-based wastewater monitoring for assessing the environmental release of residues and related ecological risks. The acute immobilization of median effect concentrations (EC50) was 25.6 mg L-1 for INH, 80.9 mg L-1 for RMP, and 188.8 mg L-1 for EMB, as toxic units (TUs) for assessing mixture toxicity. The ternary mixture exhibited the lowest TUs at 50 % effects with 1.12, followed by 1.28 for RMP + EMB, 1.54 for INH + RMP, and 1.93 for INH + EMB, indicating antagonistic interactions. Nevertheless, the combination index (CBI) was used to examine the mixture toxicity in response to immobilization, revealing that the ternary mixture of CBI ranged from 1.01 to 1.08, tending to have a nearly additive effect when suffering >50 % effect (at high concentration levels). The forecasted environmentally relevant concentrations of anti-TB drugs have been on downward trends with ng L-1 level from 2020 to 2030 in Kaohsiung, Taiwan. Although ecotoxicological risks from the wastewater treatment plant and receiving water in the field were slightly greater than the prediction from epidemiology-based wastewater monitoring, there were no risk concerns. Here, we achieved the establishment of evidence that anti-TB drug mixtures' interaction and epidemiological-based monitoring support a systematic approach, resolving the absence of the mixture toxicity information for anti-TB mixture risk assessment in aquatic environments.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Monitoring liver function among patients who initiated anti-tuberculosis drugs in Taiwan, 2000-2011
    Chou, H-C.
    Lin, S-W.
    Chen, W-W.
    Ke, W-M.
    Chao, P-H.
    Hsiao, F-Y.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2014, 18 (10) : 1245 - 1251
  • [32] Drug lymphocyte stimulation test is not useful for side effects of anti-tuberculosis drugs despite its timing
    Miwa, S.
    Suzuki, Y.
    Shirai, M.
    Ohba, H.
    Kanai, M.
    Eifuku, T.
    Suda, T.
    Hayakawa, H.
    Chida, K.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (09) : 1265 - 1269
  • [33] Evaluation of Nanocarrier-Based Dry Powder Formulations for Inhalation with Special Reference to Anti-Tuberculosis Drugs
    Patil, Tulshidas S.
    Deshpande, Ashwini
    Shende, Pravin
    Deshpande, Shirish
    Gaud, Ram
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2019, 36 (03): : 239 - 276
  • [34] TiO2-based materials for the degradation of anti-tuberculosis drugs and dyes: challenges and future perspectives
    Abouri, Mariyem
    Elouardi, Mohammed
    El Hamidi, Adnane
    Mabrouki, Jamal
    El Belghiti, Mohammed Alaoui
    Lopez, Moises Canle
    EURO-MEDITERRANEAN JOURNAL FOR ENVIRONMENTAL INTEGRATION, 2025, 10 (01) : 79 - 100
  • [35] A multi-analyte panel for non-invasive pharmacokinetic monitoring of second-line anti-tuberculosis drugs
    Gerona, Roy
    Wen, Anita
    Koss, Catherine
    Bacchetti, Peter
    Gandhi, Monica
    Metcalfe, John
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (07) : 991 - 992
  • [36] Mefloquine synergism with anti-tuberculosis drugs and correlation to membrane effects: Biologic, spectroscopic and molecular dynamics simulations studies
    dos Santos, Marinalva Cardoso
    Scaini, Joao Luis Rheingantz
    Lopes, Marcio
    Rodrigues, Beatriz Gonalves
    Silva, Nichole Osti
    Borges, Carla Roberta Lopes
    dos Santos, Sandra Cruz
    Machado, Karina dos Santos
    Werhli, Adriano Velasque
    da Silva, Pedro Eduardo Almeida
    Lourenco, Maria C. S.
    da Silva, Emerson T.
    de Souza, Marcus V. N.
    de Lima, Vania Rodrigues
    Goncalves, Raoni Schroeder B.
    BIOORGANIC CHEMISTRY, 2021, 110
  • [37] Mefloquine synergism with anti-tuberculosis drugs and correlation to membrane effects: Biologic, spectroscopic and molecular dynamics simulations studies
    dos Santos, Marinalva Cardoso
    Rheingantz Scaini, Joao Luis
    Costa Lopes, Marcio Vinicius
    Rodrigues, Beatriz Goncalves
    Silva, Nichole Osti
    Lopes Borges, Carla Roberta
    dos Santos, Sandra Cruz
    Machado, Karina dos Santos
    Werhli, Adriano Velasque
    Almeida da Silva, Pedro Eduardo
    Lourenco, Maria C. S.
    da Silva, Emerson T.
    de Souza, Marcus V. N.
    de Lima, Vania Rodrigues
    Goncalves, Raoni Schroeder B.
    BIOORGANIC CHEMISTRY, 2021, 110
  • [38] Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea:: rates, risk factors, genotyping of gene mutations and molecular epidemiology
    Tudó, G
    González, J
    Obama, R
    Rodríguez, JM
    Franco, JR
    Espasa, M
    Simarro, PP
    Escaramís, G
    Ascaso, C
    García, A
    de Anta, MTJ
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2004, 8 (01) : 15 - 22
  • [39] PHARMACOECONOMIC AND PHARMACOEPIDEMIOLOGICAL ANALYSIS OF THE USE OF DRUGS IN AN ANTI-TUBERCULOSIS HOSPITAL BASED ON THE LOCAL REAL-WORLD DATA
    Kolbin, A.
    Velum, I
    Balykina, Y.
    Panteleev, A.
    Proskurin, M.
    VALUE IN HEALTH, 2022, 25 (07) : S394 - S394
  • [40] First-line anti-tuberculosis drugs induce hepatotoxicity: A novel mechanism based on a urinary metabolomics platform
    Cao, Jun
    Mi, Yijun
    Shi, Cuilin
    Bian, Yicong
    Huang, Chenrong
    Ye, Zhijian
    Liu, Linsheng
    Miao, Liyan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (02) : 485 - 491